| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
|
Wang-Lopez, Qian
|
|
2015
|
95 |
1 |
p. 88-104
17 p.
|
article
|
| 2 |
Editorial Board
|
|
|
2015
|
95 |
1 |
p. IFC-
1 p.
|
article
|
| 3 |
Erdheim–Chester disease: A systematic review
|
Cives, Mauro
|
|
2015
|
95 |
1 |
p. 1-11
11 p.
|
article
|
| 4 |
HER2-positive metastatic breast cancer: A changing scenario
|
Mustacchi, G.
|
|
2015
|
95 |
1 |
p. 78-87
10 p.
|
article
|
| 5 |
Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: A literature analysis
|
Bouma, Grietje
|
|
2015
|
95 |
1 |
p. 26-37
12 p.
|
article
|
| 6 |
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
|
Gnoni, Antonio
|
|
2015
|
95 |
1 |
p. 46-61
16 p.
|
article
|
| 7 |
Molecular targeted therapies in advanced or metastatic chordoma patients: Facts and hypotheses
|
Lebellec, Loïc
|
|
2015
|
95 |
1 |
p. 125-131
7 p.
|
article
|
| 8 |
Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia
|
Pullarkat, Vinod
|
|
2015
|
95 |
1 |
p. 38-45
8 p.
|
article
|
| 9 |
Thoracoscopic resection of pulmonary metastasis: Current practice and results
|
Perentes, Jean Yannis
|
|
2015
|
95 |
1 |
p. 105-113
9 p.
|
article
|
| 10 |
Treating metastatic sarcomas locally: A paradoxe, a rationale, an evidence?
|
Olivier, Timothée
|
|
2015
|
95 |
1 |
p. 62-77
16 p.
|
article
|
| 11 |
Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: Opportunities for signaling-adapted therapies
|
Ree, Anne Hansen
|
|
2015
|
95 |
1 |
p. 114-124
11 p.
|
article
|
| 12 |
Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis
|
Yun, Seongseok
|
|
2015
|
95 |
1 |
p. 12-25
14 p.
|
article
|
Journal description